首页 > 最新文献

Actas espanolas de psiquiatria最新文献

英文 中文
The Symbolism in a Case of Hysterical Psychosis. 癔病性精神病案例中的象征意义。
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-02-01
Flavia Di Michele, Fiamma Rinaldi

The authors take inspiration from a case of hysterical psychosis to illustrate a typical condition of this evocative disease: the symbolic language of hysteria, conjurer of archetypical images. The authors encourage the clinician not to decode such aspects in rational analytical terms, rather to have a more wide-open approach that promotes the emergence of the individual unconscious, reconnecting with the collective imagination. This approach could help psychiatrists better understand a subject's inner experiences and interpersonal behavior.

作者从一例癔症性精神病中汲取灵感,说明了这种令人回味的疾病的典型症状:癔症的象征性语言,原型图像的创造者。作者鼓励临床医生不要从理性分析的角度来解读这些方面,而是采用一种更加开放的方法,促进个人无意识的出现,重新与集体想象力建立联系。这种方法可以帮助精神科医生更好地理解受试者的内心体验和人际交往行为。
{"title":"The Symbolism in a Case of Hysterical Psychosis.","authors":"Flavia Di Michele, Fiamma Rinaldi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The authors take inspiration from a case of hysterical psychosis to illustrate a typical condition of this evocative disease: the symbolic language of hysteria, conjurer of archetypical images. The authors encourage the clinician not to decode such aspects in rational analytical terms, rather to have a more wide-open approach that promotes the emergence of the individual unconscious, reconnecting with the collective imagination. This approach could help psychiatrists better understand a subject's inner experiences and interpersonal behavior.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 1","pages":"66-69"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10926011/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiomania: A Case Report of a Manic Episode Potentially Induced by the Interaction of Clarithromycin and Amoxicillin during H. Pylori Eradication Therapy. 抗生素躁狂症:幽门螺杆菌根除治疗期间克拉霉素和阿莫西林相互作用可能诱发狂躁症的病例报告。
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-02-01
Juan Pablo Carrasco, Eduardo Jesús Aguilar

Antibiomanic episodes, or as the DSM-5 refers to them, drug-induced manic episodes, pose a clinical challenge that is still poorly understood. There is insufficient information on the most common clinical presentation, patient profile, or underlying aetiopathogenic mechanisms. We present the clinical case of a 67-year-old woman who, after starting treatment (clarithromycin and amoxicillin) for the eradication of Helicobacter pylori, bacteria presented with a brief manic episode, which resolved after withdrawal of both drugs and with antipsychotic treatment. The possible interaction of both drugs, as GABA antagonists, in the generation of such episodes is discussed, and the clinical importance of such episodes in psychiatric emergency departments and liaison and interconsultation psychiatry, is highlighted.

抗生素躁狂发作,或 DSM-5 所称的药物诱发的躁狂发作,是一项临床挑战,但人们对它的了解仍然很少。有关最常见的临床表现、患者特征或潜在致病机制的信息尚不充分。我们介绍了一位 67 岁女性的临床病例,她在开始接受根除幽门螺旋杆菌的治疗(克拉霉素和阿莫西林)后,细菌引起了短暂的躁狂发作。本文讨论了这两种药物作为 GABA 拮抗剂在产生此类发作中可能存在的相互作用,并强调了此类发作在精神病急诊科、联络和会诊精神病学中的临床重要性。
{"title":"Antibiomania: A Case Report of a Manic Episode Potentially Induced by the Interaction of Clarithromycin and Amoxicillin during H. Pylori Eradication Therapy.","authors":"Juan Pablo Carrasco, Eduardo Jesús Aguilar","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Antibiomanic episodes, or as the DSM-5 refers to them, drug-induced manic episodes, pose a clinical challenge that is still poorly understood. There is insufficient information on the most common clinical presentation, patient profile, or underlying aetiopathogenic mechanisms. We present the clinical case of a 67-year-old woman who, after starting treatment (clarithromycin and amoxicillin) for the eradication of Helicobacter pylori, bacteria presented with a brief manic episode, which resolved after withdrawal of both drugs and with antipsychotic treatment. The possible interaction of both drugs, as GABA antagonists, in the generation of such episodes is discussed, and the clinical importance of such episodes in psychiatric emergency departments and liaison and interconsultation psychiatry, is highlighted.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 1","pages":"57-59"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10926010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the Therapeutic Value of Shexiang Tongxin Dropping Pills in Patients with Stable Angina Pectoris of Coronary Heart Disease Complicated with Cognitive Impairment. 射香通心滴丸对冠心病稳定型心绞痛并发认知障碍患者的治疗价值研究
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-02-01
Jiajia Cui, Quanjun Pu

Background: There is a pressing need to identify pharmaceuticals that are both safe and efficacious, with lower toxicity, for the treatment of stable angina pectoris in individuals suffering from coronary heart disease. The aim of this paper is to explore the therapeutic value of Shexiang Tongxin Dropping Pills in patients with stable angina pectoris of coronary heart disease complicated with cognitive impairment.

Methods: 200 patients with stable angina pectoris combined with cognitive dysfunction and coronary heart disease admitted to our hospital from January 2022 to June 2023 were retrospectively selected as the study objects. According to the treatment method, the subjects were divided into a control group and a study group, with 100 cases in each group. The control group received conventional oral Western medicine, and the study group underwent treatment with Shexiang Tongxin Dropping Pills in addition to traditional Western medicine. The course of treatment was eight weeks. The enhancement in angina pectoris, cognitive function level, self-care ability, and clinical efficacy of both groups were assessed by comparing the conditions before and after the treatment.

Results: After treatment, the frequency and duration of angina pectoris attacks in both groups were significantly lower than before, and the study group was lower than the control group (p < 0.05). The Montreal Cognitive Assessment (MoCA) score of both groups was higher than before, and the score of the study group was significantly higher than that of the control group (p < 0.05). Neuropsychiatric Inventory (NPI) scores in both groups were significantly lower than before, and the scores of the study group were significantly lower than those of the control group (p < 0.05). Traditional Chinese Medicine (TCM) syndrome scores in both groups were significantly lower than before, and the scores of the study group were significantly lower than those of the control group (p < 0.05). After treatment, the total effective rate of the control group and the study group was 81.00% and 93.00%, respectively, and the total clinical effective rate of the study group was significantly higher than that of the control group (p < 0.05).

Conclusion: Shexiang Tongxin Dropping Pills can effectively reduce the incidence of angina pectoris in patients with stable angina pectoris complicated with coronary heart disease and cognitive dysfunction. It can also regulate the patient's neurological function, improve their cognitive level, and significantly improve clinical efficacy.

背景:冠心病稳定型心绞痛的治疗迫切需要安全有效、毒性较低的药物。方法:回顾性选取我院2022年1月至2023年6月收治的200例冠心病稳定型心绞痛合并认知功能障碍患者作为研究对象。根据治疗方法将研究对象分为对照组和研究组,每组各100例。对照组接受常规口服西药治疗,研究组在传统西药治疗的基础上使用 "歙县通心滴丸 "进行治疗。疗程为八周。通过比较治疗前后的情况,评估两组患者心绞痛、认知功能水平、自理能力和临床疗效的改善情况:治疗后,两组心绞痛发作频率和持续时间均明显低于治疗前,研究组低于对照组(P < 0.05)。两组患者的蒙特利尔认知评估(MoCA)得分均高于治疗前,研究组明显高于对照组(P < 0.05)。两组患者的神经精神量表(Neuropsychiatric Inventory,NPI)评分均明显低于治疗前,研究组的评分明显低于对照组(P<0.05)。两组患者的中医证候评分均明显低于治疗前,研究组明显低于对照组(P<0.05)。治疗后,对照组和研究组的总有效率分别为81.00%和93.00%,研究组的临床总有效率明显高于对照组(P<0.05):结论:对于冠心病合并认知功能障碍的稳定型心绞痛患者,"十味通心滴丸 "能有效降低心绞痛的发生率,同时还能调节患者的心率。同时还能调节患者的神经功能,改善其认知水平,显著提高临床疗效。
{"title":"Study on the Therapeutic Value of Shexiang Tongxin Dropping Pills in Patients with Stable Angina Pectoris of Coronary Heart Disease Complicated with Cognitive Impairment.","authors":"Jiajia Cui, Quanjun Pu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>There is a pressing need to identify pharmaceuticals that are both safe and efficacious, with lower toxicity, for the treatment of stable angina pectoris in individuals suffering from coronary heart disease. The aim of this paper is to explore the therapeutic value of Shexiang Tongxin Dropping Pills in patients with stable angina pectoris of coronary heart disease complicated with cognitive impairment.</p><p><strong>Methods: </strong>200 patients with stable angina pectoris combined with cognitive dysfunction and coronary heart disease admitted to our hospital from January 2022 to June 2023 were retrospectively selected as the study objects. According to the treatment method, the subjects were divided into a control group and a study group, with 100 cases in each group. The control group received conventional oral Western medicine, and the study group underwent treatment with Shexiang Tongxin Dropping Pills in addition to traditional Western medicine. The course of treatment was eight weeks. The enhancement in angina pectoris, cognitive function level, self-care ability, and clinical efficacy of both groups were assessed by comparing the conditions before and after the treatment.</p><p><strong>Results: </strong>After treatment, the frequency and duration of angina pectoris attacks in both groups were significantly lower than before, and the study group was lower than the control group (p < 0.05). The Montreal Cognitive Assessment (MoCA) score of both groups was higher than before, and the score of the study group was significantly higher than that of the control group (p < 0.05). Neuropsychiatric Inventory (NPI) scores in both groups were significantly lower than before, and the scores of the study group were significantly lower than those of the control group (p < 0.05). Traditional Chinese Medicine (TCM) syndrome scores in both groups were significantly lower than before, and the scores of the study group were significantly lower than those of the control group (p < 0.05). After treatment, the total effective rate of the control group and the study group was 81.00% and 93.00%, respectively, and the total clinical effective rate of the study group was significantly higher than that of the control group (p < 0.05).</p><p><strong>Conclusion: </strong>Shexiang Tongxin Dropping Pills can effectively reduce the incidence of angina pectoris in patients with stable angina pectoris complicated with coronary heart disease and cognitive dysfunction. It can also regulate the patient's neurological function, improve their cognitive level, and significantly improve clinical efficacy.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 1","pages":"37-44"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10926016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Transcranial Magnetic Stimulation Combined with Sertraline on Cognitive Level, Inflammatory Response and Neurological Function in Depressive Disorder Patients with Non-suicidal Self-injury Behavior. 经颅磁刺激联合舍曲林对有非自杀性自伤行为的抑郁症患者的认知水平、炎症反应和神经功能的影响
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-02-01
Jun Liu, Juan Guan, Jie Xiong, Fang Wang
<p><strong>Background: </strong>Depressive disorder is a chronic mental illness characterized by persistent low mood as its primary clinical symptom. Currently, psychotherapy and drug therapy stand as the primary treatment modalities in clinical practice, offering a certain degree of relief from negative emotions for patients. Nevertheless, sole reliance on drug therapy exhibits a delayed impact on neurotransmitters, and long-term usage often results in adverse side effects such as nausea, drowsiness, and constipation, significantly impeding medication adherence. This study aims to investigate the impact of combining transcranial magnetic stimulation with sertraline on the cognitive level, inflammatory response, and neurological function in patients with depressive disorder who engage in non-suicidal self-injury (NSSI) behavior.</p><p><strong>Methods: </strong>A total of 130 depressive patients NSSI behavior, who were admitted to our hospital from December 2020 to February 2023, were selected as the subjects for this research. The single-group (65 cases) received treatment with oral sertraline hydrochloride tablets, while the combination group (65 cases) underwent repetitive transcranial magnetic stimulation (rTMS) in conjunction with sertraline. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was utilized to assess the depression status and cognitive function levels of both groups. Additionally, the enzyme-linked immunosorbent assay (ELISA) was employed to measure serum levels of inflammatory factors, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). Furthermore, serum levels of neurotransmitters (norepinephrine (NE), dopamine (DA), 5-hydroxytryptamine (5-HT)) and neuro-cytokines (brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), glial fibrillary acidic protein (GFAP)) were assessed. The clinical effects of the interventions on both groups were then evaluated.</p><p><strong>Results: </strong>Following the treatment, the combination group exhibited significantly higher levels of immediate memory, delayed memory, attention, visual function, and language function compared to the single group, with statistically significant differences (p < 0.05). Additionally, the serum levels of TNF-α, IL-1β, IL-6, and GFAP in the combination group were lower than those in the single group, while the levels of BDNF and NGF were higher in the combination group compared to the single group. These differences were also statistically significant (p < 0.05). Simultaneously, the total clinical effective rate in the combination group reached 95.38%, surpassing the 84.61% observed in the single group, and the disparity between the two groups was statistically significant (p < 0.05).</p><p><strong>Conclusions: </strong>The combined use of rTMS and sertraline in treating patients with depressive disorder exhibiting NSSI behavior has proven to be effective in enhancing cognitive func
背景介绍抑郁症是一种慢性精神疾病,其主要临床症状是持续的情绪低落。目前,临床上主要采用心理治疗和药物治疗,在一定程度上缓解了患者的负面情绪。然而,单纯依赖药物治疗对神经递质的影响具有滞后性,长期服用往往会产生恶心、嗜睡、便秘等不良副作用,严重影响了患者的服药依从性。本研究旨在探讨经颅磁刺激与舍曲林联合应用对有非自杀性自伤(NSSI)行为的抑郁症患者的认知水平、炎症反应和神经功能的影响:选取我院 2020 年 12 月至 2023 年 2 月收治的 130 例有非自杀自伤行为的抑郁症患者作为研究对象。单一组(65 例)接受盐酸舍曲林口服片治疗,联合组(65 例)在接受舍曲林治疗的同时接受重复经颅磁刺激(rTMS)治疗。两组患者均使用神经心理状态评估可重复电池(RBANS)评估抑郁状态和认知功能水平。此外,还采用酶联免疫吸附试验(ELISA)测定血清中的炎症因子水平,包括肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)和白细胞介素-6(IL-6)。此外,还评估了血清中神经递质(去甲肾上腺素(NE)、多巴胺(DA)、5-羟色胺(5-HT))和神经细胞因子(脑源性神经营养因子(BDNF)、神经生长因子(NGF)、神经胶质纤维酸性蛋白(GFAP))的水平。然后评估了两组干预措施的临床效果:治疗后,联合组的即时记忆、延迟记忆、注意力、视觉功能和语言功能水平明显高于单一组,差异有统计学意义(P < 0.05)。此外,联合组的血清 TNF-α、IL-1β、IL-6 和 GFAP 水平低于单一组,而联合组的 BDNF 和 NGF 水平高于单一组,差异有统计学意义(P < 0.05)。这些差异也具有统计学意义(P < 0.05)。同时,联合组的临床总有效率达到了 95.38%,超过了单一组的 84.61%,两组之间的差异有统计学意义(P < 0.05):经颅磁刺激与舍曲林联合用于治疗表现出 NSSI 行为的抑郁症患者,在增强患者认知功能、减轻炎症反应、提高神经递质和神经细胞因子水平方面被证明是有效的。
{"title":"Effects of Transcranial Magnetic Stimulation Combined with Sertraline on Cognitive Level, Inflammatory Response and Neurological Function in Depressive Disorder Patients with Non-suicidal Self-injury Behavior.","authors":"Jun Liu, Juan Guan, Jie Xiong, Fang Wang","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Depressive disorder is a chronic mental illness characterized by persistent low mood as its primary clinical symptom. Currently, psychotherapy and drug therapy stand as the primary treatment modalities in clinical practice, offering a certain degree of relief from negative emotions for patients. Nevertheless, sole reliance on drug therapy exhibits a delayed impact on neurotransmitters, and long-term usage often results in adverse side effects such as nausea, drowsiness, and constipation, significantly impeding medication adherence. This study aims to investigate the impact of combining transcranial magnetic stimulation with sertraline on the cognitive level, inflammatory response, and neurological function in patients with depressive disorder who engage in non-suicidal self-injury (NSSI) behavior.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A total of 130 depressive patients NSSI behavior, who were admitted to our hospital from December 2020 to February 2023, were selected as the subjects for this research. The single-group (65 cases) received treatment with oral sertraline hydrochloride tablets, while the combination group (65 cases) underwent repetitive transcranial magnetic stimulation (rTMS) in conjunction with sertraline. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was utilized to assess the depression status and cognitive function levels of both groups. Additionally, the enzyme-linked immunosorbent assay (ELISA) was employed to measure serum levels of inflammatory factors, including tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6). Furthermore, serum levels of neurotransmitters (norepinephrine (NE), dopamine (DA), 5-hydroxytryptamine (5-HT)) and neuro-cytokines (brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), glial fibrillary acidic protein (GFAP)) were assessed. The clinical effects of the interventions on both groups were then evaluated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Following the treatment, the combination group exhibited significantly higher levels of immediate memory, delayed memory, attention, visual function, and language function compared to the single group, with statistically significant differences (p &lt; 0.05). Additionally, the serum levels of TNF-α, IL-1β, IL-6, and GFAP in the combination group were lower than those in the single group, while the levels of BDNF and NGF were higher in the combination group compared to the single group. These differences were also statistically significant (p &lt; 0.05). Simultaneously, the total clinical effective rate in the combination group reached 95.38%, surpassing the 84.61% observed in the single group, and the disparity between the two groups was statistically significant (p &lt; 0.05).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;The combined use of rTMS and sertraline in treating patients with depressive disorder exhibiting NSSI behavior has proven to be effective in enhancing cognitive func","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 1","pages":"28-36"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10928317/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of Disease Severity, Anxiety and Depression in Obsessive-Compulsive Disorder Patients with Different Insight. 比较不同洞察力强迫症患者的疾病严重程度、焦虑和抑郁程度。
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-02-01
Cheng Zhu, Yueqi Huang, Wenjing Zhu, Xiaoying Jiang, Yan Liang, Wenxin Tang, Ziming Xu

Background: Significant individual differences exist in the insight of patients with obsessive-compulsive disorder (OCD), and the clinical characteristics of OCD patients with varying levels of insight are not entirely uniform. This study aims to investigate disparities in disease severity, anxiety, and depression status among OCD patients with differing levels of insight, with the goal of generating novel treatment strategies for OCD.

Methods: A total of 114 patients diagnosed with OCD were recruited from the Department of Psychology at Affiliated Mental Health Center & Hangzhou Seventh People's Hospital to participate in this research. Based on their Total Insight and Treatment Attitude Questionnaire (ITAQ) scores, the patients were divided into two groups: Group OCD with high insight (referred to as Group OCD-HI, ITAQ score ≥20 points, n = 80) and Group OCD with low insight (referred to as Group OCD-LI, ITAQ score <20 points, n = 34). Subsequently, the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Hamilton Anxiety Scale (HAMA), and Hamilton Depression Scale (HAMD) scores were compared between the two groups. All questionnaires for this study were completed by experienced psychiatrists.

Results: The Y-BOCS scores for YB1, YB2, YB4, YB5, YB6, YB9, and the total Y-BOCS scores in Group OCD-HI were significantly higher than those in Group OCD-LI (p < 0.05). Conversely, Group OCD-HI exhibited significantly lower HAMA and HAMD scores compared to Group OCD-LI (p < 0.05). Furthermore, the total ITAQ score displayed a significant negative correlation with the total Y-BOCS, HAMA, and HAMD scores (p < 0.05).

Conclusions: This study revealed that certain OCD patients exhibit incomplete insight, and this lack of insight is strongly associated with increased disease severity and heightened levels of anxiety and depression. It is hoped that by enhancing the insight of OCD patients, the goal of ameliorating disease symptoms and alleviating negative emotions can be attained.

背景:强迫症(OCD)患者的洞察力存在明显的个体差异,而洞察力不同的强迫症患者的临床特征也不完全一致。本研究旨在调查具有不同洞察力的强迫症患者在疾病严重程度、焦虑和抑郁状况方面的差异,从而为强迫症制定新的治疗策略:方法:本研究从杭州市第七人民医院附属精神卫生中心心理科招募了114名强迫症患者。根据患者的洞察力和治疗态度问卷(ITAQ)总分,将患者分为两组:高洞察力强迫症组(简称OCD-HI组,ITAQ评分≥20分,n=80)和低洞察力强迫症组(简称OCD-LI组,ITAQ评分结果):OCD-HI 组的 YB1、YB2、YB4、YB5、YB6、YB9 的 Y-BOCS 分数和 Y-BOCS 总分显著高于 OCD-LI 组(P < 0.05)。相反,与 OCD-LI 组相比,OCD-HI 组的 HAMA 和 HAMD 分数明显较低(P < 0.05)。此外,ITAQ 总分与 Y-BOCS、HAMA 和 HAMD 总分呈显著负相关(p < 0.05):本研究揭示了某些强迫症患者表现出不完全的洞察力,而这种洞察力的缺乏与疾病严重程度的增加以及焦虑和抑郁水平的升高密切相关。希望通过提高强迫症患者的洞察力,达到改善疾病症状和缓解负面情绪的目的。
{"title":"Comparison of Disease Severity, Anxiety and Depression in Obsessive-Compulsive Disorder Patients with Different Insight.","authors":"Cheng Zhu, Yueqi Huang, Wenjing Zhu, Xiaoying Jiang, Yan Liang, Wenxin Tang, Ziming Xu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Significant individual differences exist in the insight of patients with obsessive-compulsive disorder (OCD), and the clinical characteristics of OCD patients with varying levels of insight are not entirely uniform. This study aims to investigate disparities in disease severity, anxiety, and depression status among OCD patients with differing levels of insight, with the goal of generating novel treatment strategies for OCD.</p><p><strong>Methods: </strong>A total of 114 patients diagnosed with OCD were recruited from the Department of Psychology at Affiliated Mental Health Center & Hangzhou Seventh People's Hospital to participate in this research. Based on their Total Insight and Treatment Attitude Questionnaire (ITAQ) scores, the patients were divided into two groups: Group OCD with high insight (referred to as Group OCD-HI, ITAQ score ≥20 points, n = 80) and Group OCD with low insight (referred to as Group OCD-LI, ITAQ score <20 points, n = 34). Subsequently, the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), Hamilton Anxiety Scale (HAMA), and Hamilton Depression Scale (HAMD) scores were compared between the two groups. All questionnaires for this study were completed by experienced psychiatrists.</p><p><strong>Results: </strong>The Y-BOCS scores for YB1, YB2, YB4, YB5, YB6, YB9, and the total Y-BOCS scores in Group OCD-HI were significantly higher than those in Group OCD-LI (p < 0.05). Conversely, Group OCD-HI exhibited significantly lower HAMA and HAMD scores compared to Group OCD-LI (p < 0.05). Furthermore, the total ITAQ score displayed a significant negative correlation with the total Y-BOCS, HAMA, and HAMD scores (p < 0.05).</p><p><strong>Conclusions: </strong>This study revealed that certain OCD patients exhibit incomplete insight, and this lack of insight is strongly associated with increased disease severity and heightened levels of anxiety and depression. It is hoped that by enhancing the insight of OCD patients, the goal of ameliorating disease symptoms and alleviating negative emotions can be attained.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 1","pages":"10-18"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10926014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058443","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Psychotic Disorder after Left Posterior Cerebral Artery Stroke-An Atypical Event. 左侧大脑后动脉卒中后的精神障碍--一种非典型事件。
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2024-02-01
Henrique Nascimento, Bárbara Almeida

Introduction: Stroke survivors usually present physical and neuropsychiatric complications. Post-stroke psychosis (PSPsy) is a particularly neglected sequel despite its disruptive nature.

Objectives: To present a case of early emerging neuropsychiatric symptoms following a left posterior cerebral artery (PCA) stroke. To review and discuss PSPsy clinical manifestations, pathophysiology, and clinical outcomes.

Clinical case: A previously autonomous 68-year-old woman with vascular risk factors and depressive disorder presented to the emergency department with a 5-day history of disorientation, motor aphasia, and right hypoesthesia. Computer tomography revealed a left PCA stroke. She was started on acetylsalicylic acid and rosuvastatin and discharged the next day. Afterward, the patient developed a depressive mood, emotional lability, periods of confusion, delusions of persecution, guilt and unworthiness, auditory hallucinations, and suicide ideation. She was admitted to a psychiatric hospital and started on risperidone with a good response, being discharged after 15 days with the resolution of psychiatric symptoms.

Conclusions: PSPsy is more common after right hemisphere lesions and usually develops after some months. Nevertheless, our patient presented PSPsy following an ischemic event of the left PCA, with neuropsychiatric symptomatology dominating the clinic since the beginning. The involvement of the retrosplenial cortex or its connections was likely important for this atypical presentation. Due to the lack of guidelines on approaching PSPsy, most patients are treated with the same strategies used for non-stroke patients. A better comprehension of the anatomical basis underlining the symptomatology in these patients could deepen the understanding of psychosis and psychotic disorders.

简介脑卒中幸存者通常会出现身体和神经精神并发症。卒中后精神病(PSPsy)尽管具有破坏性,但却是一种特别容易被忽视的后遗症:介绍一例左侧大脑后动脉(PCA)卒中后早期出现的神经精神症状。回顾并讨论 PSPsy 的临床表现、病理生理学和临床结果:临床病例:一名68岁的女性患者,既往有自主神经功能,伴有血管危险因素和抑郁障碍,因5天前出现的定向障碍、运动性失语和右侧感觉减退到急诊科就诊。计算机断层扫描显示她左侧 PCA 中风。患者开始服用乙酰水杨酸和洛伐他汀,并于第二天出院。之后,患者出现了抑郁情绪、情绪不稳、意识混乱、迫害妄想、内疚和不值得、幻听以及自杀念头。她被送进精神病院,开始服用利培酮,反应良好,15天后精神症状缓解出院:结论:PSPsy 在右半球病变后更为常见,通常在数月后发病。然而,我们的患者是在左侧 PCA 缺血事件后出现的 PSPsy,从一开始就以神经精神症状为主。脾后部皮质或其连接部位受累很可能是这种非典型表现的重要原因。由于缺乏治疗 PSPsy 的指南,大多数患者的治疗策略与非卒中患者相同。更好地理解这些患者症状的解剖学基础可以加深对精神病和精神病性障碍的理解。
{"title":"Psychotic Disorder after Left Posterior Cerebral Artery Stroke-An Atypical Event.","authors":"Henrique Nascimento, Bárbara Almeida","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Stroke survivors usually present physical and neuropsychiatric complications. Post-stroke psychosis (PSPsy) is a particularly neglected sequel despite its disruptive nature.</p><p><strong>Objectives: </strong>To present a case of early emerging neuropsychiatric symptoms following a left posterior cerebral artery (PCA) stroke. To review and discuss PSPsy clinical manifestations, pathophysiology, and clinical outcomes.</p><p><strong>Clinical case: </strong>A previously autonomous 68-year-old woman with vascular risk factors and depressive disorder presented to the emergency department with a 5-day history of disorientation, motor aphasia, and right hypoesthesia. Computer tomography revealed a left PCA stroke. She was started on acetylsalicylic acid and rosuvastatin and discharged the next day. Afterward, the patient developed a depressive mood, emotional lability, periods of confusion, delusions of persecution, guilt and unworthiness, auditory hallucinations, and suicide ideation. She was admitted to a psychiatric hospital and started on risperidone with a good response, being discharged after 15 days with the resolution of psychiatric symptoms.</p><p><strong>Conclusions: </strong>PSPsy is more common after right hemisphere lesions and usually develops after some months. Nevertheless, our patient presented PSPsy following an ischemic event of the left PCA, with neuropsychiatric symptomatology dominating the clinic since the beginning. The involvement of the retrosplenial cortex or its connections was likely important for this atypical presentation. Due to the lack of guidelines on approaching PSPsy, most patients are treated with the same strategies used for non-stroke patients. A better comprehension of the anatomical basis underlining the symptomatology in these patients could deepen the understanding of psychosis and psychotic disorders.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"52 1","pages":"60-65"},"PeriodicalIF":1.5,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10926015/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140058447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association and Interacting Factors between Bronchial Asthma and Attention-deficit Hyperactivity Disorder in Children: Meta-analysis and Systematic Review. 儿童支气管哮喘与注意力缺陷多动障碍之间的关联和相互作用因素:元分析和系统综述》(Meta-analysis and Systematic Review)。
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2023-12-01
Yongjun Dai, Ni Jin

Background: This study aims to systematically assess the possible link between bronchial asthma usage and attention-deficit hyperactivity disorder (ADHD) in children.

Methods: PubMed, Web of Science, ScienceDirect, CNKI, Wanfang, and the China Biological Medicine Database (CBM) were searched for relevant articles published from database inception until September 28, 2023. The statistical analyses were conducted using Stata 15.1 software, followed by a quantitative meta-analysis to synthesize the results of the odds ratios (ORs) and their corresponding 95% confidence intervals (CIs).

Results: A total of 10 articles involving 729,375 participants were included in the meta-analysis. The overall analysis revealed a statistically significant association between ADHD and an increased likelihood of having bronchial asthma, as indicated by a pooled odds ratio (OR) of 1.46 and a 95% confidence interval (CI) ranging from 1.41 to 1.51, p < 0.001, I2 = 58%. Potential associated factors linking bronchial asthma and ADHD in children include demographic characteristics, healthcare access, socioeconomic factors, comorbidities, genetic susceptibility, immune dysregulation, chronic conditions, growth and development factors, and parental/environmental influences.

Conclusion: This systematic review and meta-analysis presents convincing evidence for a notable link between bronchial asthma and ADHD in children. The results indicate an increased likelihood of bronchial asthma among children with ADHD compared to those without the condition. Additionally, various potential factors can underlie the association between bronchial asthma and ADHD in children, necessitating further research to fully comprehend their complex relationship. These findings have implications for clinical practice, highlighting the need for an integrated approach in managing asthma and ADHD.

背景:本研究旨在系统评估支气管哮喘与儿童注意力缺陷多动症(ADHD)之间可能存在的联系:本研究旨在系统评估支气管哮喘的使用与儿童注意缺陷多动障碍(ADHD)之间可能存在的联系:方法:检索PubMed、Web of Science、ScienceDirect、CNKI、万方数据库和中国生物医学数据库(CBM)中自数据库建立至2023年9月28日发表的相关文章。使用Stata 15.1软件进行统计分析,然后进行定量荟萃分析,综合得出几率比(ORs)及其相应的95%置信区间(CIs)的结果:荟萃分析共纳入了 10 篇文章,涉及 729 375 名参与者。总体分析结果显示,多动症与支气管哮喘患病几率增加之间存在统计学意义上的显著关联,汇总几率比(OR)为1.46,95%置信区间(CI)为1.41-1.51,P < 0.001,I2 = 58%。将儿童支气管哮喘与多动症联系在一起的潜在相关因素包括人口统计学特征、医疗保健途径、社会经济因素、合并症、遗传易感性、免疫失调、慢性疾病、生长发育因素以及父母/环境影响:本系统综述和荟萃分析提供了令人信服的证据,证明支气管哮喘与儿童多动症之间存在显著联系。研究结果表明,与非多动症儿童相比,多动症儿童患支气管哮喘的可能性更大。此外,支气管哮喘与儿童多动症之间的联系可能存在各种潜在因素,因此有必要开展进一步研究,以全面了解两者之间的复杂关系。这些研究结果对临床实践具有启示意义,强调了采用综合方法管理哮喘和多动症的必要性。
{"title":"Association and Interacting Factors between Bronchial Asthma and Attention-deficit Hyperactivity Disorder in Children: Meta-analysis and Systematic Review.","authors":"Yongjun Dai, Ni Jin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>This study aims to systematically assess the possible link between bronchial asthma usage and attention-deficit hyperactivity disorder (ADHD) in children.</p><p><strong>Methods: </strong>PubMed, Web of Science, ScienceDirect, CNKI, Wanfang, and the China Biological Medicine Database (CBM) were searched for relevant articles published from database inception until September 28, 2023. The statistical analyses were conducted using Stata 15.1 software, followed by a quantitative meta-analysis to synthesize the results of the odds ratios (ORs) and their corresponding 95% confidence intervals (CIs).</p><p><strong>Results: </strong>A total of 10 articles involving 729,375 participants were included in the meta-analysis. The overall analysis revealed a statistically significant association between ADHD and an increased likelihood of having bronchial asthma, as indicated by a pooled odds ratio (OR) of 1.46 and a 95% confidence interval (CI) ranging from 1.41 to 1.51, p < 0.001, I2 = 58%. Potential associated factors linking bronchial asthma and ADHD in children include demographic characteristics, healthcare access, socioeconomic factors, comorbidities, genetic susceptibility, immune dysregulation, chronic conditions, growth and development factors, and parental/environmental influences.</p><p><strong>Conclusion: </strong>This systematic review and meta-analysis presents convincing evidence for a notable link between bronchial asthma and ADHD in children. The results indicate an increased likelihood of bronchial asthma among children with ADHD compared to those without the condition. Additionally, various potential factors can underlie the association between bronchial asthma and ADHD in children, necessitating further research to fully comprehend their complex relationship. These findings have implications for clinical practice, highlighting the need for an integrated approach in managing asthma and ADHD.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"51 6","pages":"262-270"},"PeriodicalIF":1.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10847665/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139696643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Music Intervention on Anxiety, Depression Symptoms and Quality of Life in Breast Cancer Patients: A Meta-Analysis. 音乐干预对乳腺癌患者焦虑、抑郁症状和生活质量的影响:元分析
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2023-12-01
Ran Ran, Yinyin Ying, Weiping Zhang

Background: Music therapy is often used to relieve anxiety and depression in breast cancer patients, but the clinical effect of music therapy on breast cancer patients is still controversial. This study was a systematic review to investigate the effects of music intervention on anxiety, depression, pain, and quality of life in breast cancer patients.

Method: A computer search of PubMed, Embase, Web of Science, and The Cochrane Library repositories was conducted. We searched for randomized controlled trials (RCTs), published in English until October 2023, on the effects of music interventions on anxiety, depressive symptoms, pain levels, and quality of life in breast cancer patients. The Cochrane Manual of Systematic Review 5.3 was used to evaluate the quality of the included references, and Stata15.0 software was selected for meta-analysis of the study indicators.

Results: A total of 10 articles were included in this study, including 593 patients. Meta-analysis showed that music intervention could effectively alleviate anxiety symptoms [standardized mean difference (SMD) = -2.12, 95% confidence interval (CI): -3.17~-1.07], depression symptoms (SMD: -0.77, 95% CI: -1.47~-0.07), and pain degree (SMD: -3.47, 95% CI: -6.45~-0.48). There was no significant difference in the improvement of patients' quality of life (SMD: -0.07, 95% CI: -0.48~0.34).

Conclusion: Music intervention can effectively relieve anxiety and depression symptoms in patients with breast cancer, and reduce the degree of pain, but demonstration of its ability to improve the quality of life of patients requires additional research.

背景:音乐治疗常用于缓解乳腺癌患者的焦虑和抑郁,但音乐治疗对乳腺癌患者的临床效果仍存在争议。本研究对音乐干预对乳腺癌患者焦虑、抑郁、疼痛和生活质量的影响进行了系统回顾:方法:对 PubMed、Embase、Web of Science 和 Cochrane 图书馆资料库进行了计算机检索。我们搜索了 2023 年 10 月之前发表的关于音乐干预对乳腺癌患者焦虑、抑郁症状、疼痛程度和生活质量影响的英文随机对照试验 (RCT)。采用《Cochrane系统综述手册5.3》对纳入的参考文献进行质量评估,并选用Stata15.0软件对研究指标进行荟萃分析:结果:本研究共纳入10篇文章,包括593名患者。Meta分析结果显示,音乐干预能有效缓解焦虑症状[标准化平均差(SMD)=-2.12,95%置信区间(CI):-3.17~-1.07]、抑郁症状(SMD:-0.77,95%CI:-1.47~-0.07)和疼痛程度(SMD:-3.47,95%CI:-6.45~-0.48)。结论:音乐干预能有效缓解焦虑和抑郁:音乐干预能有效缓解乳腺癌患者的焦虑和抑郁症状,减轻疼痛程度,但其改善患者生活质量的能力还需进一步研究。
{"title":"Effects of Music Intervention on Anxiety, Depression Symptoms and Quality of Life in Breast Cancer Patients: A Meta-Analysis.","authors":"Ran Ran, Yinyin Ying, Weiping Zhang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Music therapy is often used to relieve anxiety and depression in breast cancer patients, but the clinical effect of music therapy on breast cancer patients is still controversial. This study was a systematic review to investigate the effects of music intervention on anxiety, depression, pain, and quality of life in breast cancer patients.</p><p><strong>Method: </strong>A computer search of PubMed, Embase, Web of Science, and The Cochrane Library repositories was conducted. We searched for randomized controlled trials (RCTs), published in English until October 2023, on the effects of music interventions on anxiety, depressive symptoms, pain levels, and quality of life in breast cancer patients. The Cochrane Manual of Systematic Review 5.3 was used to evaluate the quality of the included references, and Stata15.0 software was selected for meta-analysis of the study indicators.</p><p><strong>Results: </strong>A total of 10 articles were included in this study, including 593 patients. Meta-analysis showed that music intervention could effectively alleviate anxiety symptoms [standardized mean difference (SMD) = -2.12, 95% confidence interval (CI): -3.17~-1.07], depression symptoms (SMD: -0.77, 95% CI: -1.47~-0.07), and pain degree (SMD: -3.47, 95% CI: -6.45~-0.48). There was no significant difference in the improvement of patients' quality of life (SMD: -0.07, 95% CI: -0.48~0.34).</p><p><strong>Conclusion: </strong>Music intervention can effectively relieve anxiety and depression symptoms in patients with breast cancer, and reduce the degree of pain, but demonstration of its ability to improve the quality of life of patients requires additional research.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"51 6","pages":"250-261"},"PeriodicalIF":1.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10847666/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139696644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spirituality, Religiosity and Mental Health: A Clinical-care Approach. 精神、宗教信仰与心理健康:临床护理方法》。
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2023-12-01
Victor Chavarria, Josep Antoni Boix, Blanca De La Puente, Laura Gimenez, Cristina Pou, Carlos Peña-Salazar, Isabel Grimal, Josep Maria Haro, Antoni Serrano-Blanco

No abstract present.

无摘要。
{"title":"Spirituality, Religiosity and Mental Health: A Clinical-care Approach.","authors":"Victor Chavarria, Josep Antoni Boix, Blanca De La Puente, Laura Gimenez, Cristina Pou, Carlos Peña-Salazar, Isabel Grimal, Josep Maria Haro, Antoni Serrano-Blanco","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>No abstract present.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"51 6","pages":"281-282"},"PeriodicalIF":1.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10847662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139696645","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Retrospective Study on the Effect of Empowerment Psychological Intervention Led by Specialist Nurses on Post-traumatic Stress Disorder in ICU Patients. 由专科护士主导的赋权心理干预对重症监护病房患者创伤后应激障碍影响的回顾性研究。
IF 1.5 4区 医学 Q4 NEUROSCIENCES Pub Date : 2023-12-01
Jie Yu, Huiyan Zhu, Bei Han, Na Zhu

Background: Many patients in the intensive care unit (ICU) suffer from post-traumatic stress disorder (PTSD), which seriously affects the treatment, recovery, and prognosis of patients.

Objective: To observe the effect of empowerment psychological intervention on the status of PTSD in ICU patients.

Methods: A total of 86 patients with PTSD who were treated in ICU from July 2019 to December 2021 were divided into two groups according to the intervention method. The control group (n = 43) used routine psychological intervention, while the intervention group (n = 43) used empowerment psychological intervention led by specialist nurses. The Pittsburgh Sleep Quality Index (PSQI) was used to assess the sleep quality of the patients. The Resilience Questionnaire (CD-RISC) was used to evaluate the resilience of the patients, and the Post Traumatic Stress Disorder Self-Rating Scale (PTSD-SS) was used to assess the severity of the symptoms. The Hamilton Anxiety and Depression Inventory (HAMA and HAMD) was adapted to assess the degree of anxiety and depression, and the Post-Traumatic Growth Inventory (PTGI) was adapted to evaluate the post-traumatic growth of the patients.

Results: After the intervention, the total CD-RISC score and its tenacity, self-improvement, and optimism scores in the two groups were all higher than before, and the total PSQI score and its sleep quality, time, efficiency and impairment, as well as hypnotic drugs, daytime dysfunction and time to sleep were lower than before, and the CD-RISC score in the intervention group was higher than that in the control group, PSQI score was lower than that in the control group (p < 0.05). After the intervention, PTSD-SS scores and anxiety-depression scores were lower, and PTGI scores were higher in both groups than before (p < 0.05).

Conclusion: The empowerment psychological intervention led by specialist nurses applied to ICU patients with PTSD can improve their psychological resilience and sleep quality, reduce negative emotions, alleviate clinical symptoms, and promote post-traumatic growth.

背景:许多重症监护病房(ICU)的患者患有创伤后应激障碍(PTSD):许多重症监护室(ICU)患者患有创伤后应激障碍(PTSD),严重影响患者的治疗、康复和预后:观察赋权心理干预对 ICU 患者创伤后应激障碍状况的影响:选取2019年7月至2021年12月在ICU接受治疗的PTSD患者共86例,按照干预方法分为两组。对照组(n = 43)采用常规心理干预,干预组(n = 43)采用由专科护士主导的赋权心理干预。采用匹兹堡睡眠质量指数(PSQI)评估患者的睡眠质量。复原力问卷(CD-RISC)用于评估患者的复原力,创伤后应激障碍自评量表(PTSD-SS)用于评估症状的严重程度。汉密尔顿焦虑抑郁量表(HAMA和HAMD)用于评估患者的焦虑和抑郁程度,创伤后成长量表(PTGI)用于评估患者的创伤后成长情况:干预后,两组患者的CD-RISC总分及其韧性、自强、乐观评分均高于干预前,PSQI总分及其睡眠质量、时间、效率、障碍,以及催眠药物、日间功能障碍、入睡时间均低于干预前,且干预组CD-RISC评分高于对照组,PSQI评分低于对照组(P<0.05)。干预后,两组的 PTSD-SS 评分和焦虑抑郁评分均低于干预前,PTGI 评分高于干预前(P < 0.05):由专科护士主导的赋权心理干预应用于ICU创伤后应激障碍患者,可提高其心理适应能力和睡眠质量,减少负面情绪,缓解临床症状,促进创伤后成长。
{"title":"A Retrospective Study on the Effect of Empowerment Psychological Intervention Led by Specialist Nurses on Post-traumatic Stress Disorder in ICU Patients.","authors":"Jie Yu, Huiyan Zhu, Bei Han, Na Zhu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Many patients in the intensive care unit (ICU) suffer from post-traumatic stress disorder (PTSD), which seriously affects the treatment, recovery, and prognosis of patients.</p><p><strong>Objective: </strong>To observe the effect of empowerment psychological intervention on the status of PTSD in ICU patients.</p><p><strong>Methods: </strong>A total of 86 patients with PTSD who were treated in ICU from July 2019 to December 2021 were divided into two groups according to the intervention method. The control group (n = 43) used routine psychological intervention, while the intervention group (n = 43) used empowerment psychological intervention led by specialist nurses. The Pittsburgh Sleep Quality Index (PSQI) was used to assess the sleep quality of the patients. The Resilience Questionnaire (CD-RISC) was used to evaluate the resilience of the patients, and the Post Traumatic Stress Disorder Self-Rating Scale (PTSD-SS) was used to assess the severity of the symptoms. The Hamilton Anxiety and Depression Inventory (HAMA and HAMD) was adapted to assess the degree of anxiety and depression, and the Post-Traumatic Growth Inventory (PTGI) was adapted to evaluate the post-traumatic growth of the patients.</p><p><strong>Results: </strong>After the intervention, the total CD-RISC score and its tenacity, self-improvement, and optimism scores in the two groups were all higher than before, and the total PSQI score and its sleep quality, time, efficiency and impairment, as well as hypnotic drugs, daytime dysfunction and time to sleep were lower than before, and the CD-RISC score in the intervention group was higher than that in the control group, PSQI score was lower than that in the control group (p < 0.05). After the intervention, PTSD-SS scores and anxiety-depression scores were lower, and PTGI scores were higher in both groups than before (p < 0.05).</p><p><strong>Conclusion: </strong>The empowerment psychological intervention led by specialist nurses applied to ICU patients with PTSD can improve their psychological resilience and sleep quality, reduce negative emotions, alleviate clinical symptoms, and promote post-traumatic growth.</p>","PeriodicalId":7251,"journal":{"name":"Actas espanolas de psiquiatria","volume":"51 6","pages":"241-249"},"PeriodicalIF":1.5,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10847663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139696642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Actas espanolas de psiquiatria
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1